Impact of BRCA1/2 mutation status in TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple negative breast cancer Meeting Abstract
| Authors: | Isakoff, S. J.; Goss, P. E.; Mayer, E. L.; Traina, T.; Carey, L. A.; Krag, K. J.; Liu, M. C.; Rugo, H.; Stearns, V.; Come, S.; Finkelstein, D.; Hartman, A. R.; Garber, J. E.; Ryan, P. D.; Winer, E. P.; Ellisen, L. W. |
| Abstract Title: | Impact of BRCA1/2 mutation status in TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple negative breast cancer |
| Meeting Title: | 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 72 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2012 Dec 4-8 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2012-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209704901420 |
| DOI: | 10.1158/0008-5472.sabcs12-pd09-03 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PD09-03 -- Source: Wos |
